etoposide has been researched along with Leukemia, Plasma Cell in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iino, M; Nakajima, A; Shindo, H | 1 |
Arpaci, F; Ataergin, S; Cetin, T; Gunhan, O; Kaya, A; Kaya, T | 1 |
Ishige, K; Sakai, C; Takagi, T | 1 |
Arai, T; Fukutoku, M; Hirose, Y; Konda, S; Masaki, Y; Shimizu, S; Sugai, S; Takeshita, S; Takiguti, T; Yoshioka, R | 1 |
Bonini, A; Carotenuto, M; Cascavilla, N; D'Arena, G; Di Mauro, L; Greco, MM; Melillo, L; Minervini, MM; Musto, P; Sajeva, MR; Scalzulli, P | 1 |
de Wolf, JT; Hovenga, S; Klip, H; Vellenga, E | 1 |
Butch, AW; Flick, JT; Pappas, AA; Yeh, YA | 1 |
Gale, RP; Kosmo, MA | 1 |
1 review(s) available for etoposide and Leukemia, Plasma Cell
Article | Year |
---|---|
Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Plasma Cell; Melphalan; Middle Aged; Paraproteins; Remission Induction; Treatment Outcome; Vincristine | 1997 |
7 other study(ies) available for etoposide and Leukemia, Plasma Cell
Article | Year |
---|---|
[Long-term complete remission in primary plasma cell leukemia after treatment with VAD chemotherapy and tandem autologous peripheral blood stem cell transplantation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Immunoglobulin Heavy Chains; Leukemia, Plasma Cell; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Time Factors; Transplantation, Autologous | 2008 |
VAD combination chemotherapy followed by bortezomib may be an effective treatment in secondary plasma cell leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Doxorubicin; Etoposide; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Protease Inhibitors; Pyrazines; Remission Induction | 2006 |
Haematological remission and bone healing of refractory plasma cell leukaemia by chronic oral etoposide.
Topics: Etoposide; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Osteolysis; Radiography; Remission Induction | 1995 |
[Successful VEP-IFN-alpha therapy in a case of non-secretory plasma cell leukemia (BJ-kappa type)].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Immunoglobulin kappa-Chains; Immunoglobulin Light Chains; Interferon-alpha; Leukemia, Plasma Cell; Male; Prednisolone; Vindesine | 1994 |
Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Plasma Cell; Lymphocyte Count; Male; Melphalan; Mitoxantrone; Prednisone; Remission Induction; T-Lymphocyte Subsets; Transplantation Conditioning; Vincristine; Whole-Body Irradiation | 1996 |
A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cell Cycle; Cisplatin; Cyclophosphamide; Dexamethasone; Etoposide; Flow Cytometry; Humans; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Leukemia, Plasma Cell; Male; Multiple Myeloma; Neoplasms, Second Primary; Prognosis; Thalidomide | 2000 |
Plasma cell leukemia with IgA paraproteinemia and hyperviscosity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Viscosity; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Heart Failure; Humans; Immunoglobulin A; Leukemia, Plasma Cell; Male; Middle Aged; Paraproteinemias; Plasmapheresis; Prednisone; Vincristine | 1988 |